Showing 1 - 4 results of 4 for search 'Alison C Roxby', query time: 0.01s Refine Results
  1. 1
    Maternal valacyclovir and infant cytomegalovirus acquisition: a randomized controlled trial among HIV-infected women.

    Maternal valacyclovir and infant cytomegalovirus acquisition: a randomized controlled trial among HIV-infected women. by Alison C Roxby, Claire Atkinson, Kristjana Asbjörnsdóttir, Carey Farquhar, James N Kiarie, Alison L Drake, Anna Wald, Michael Boeckh, Barbra Richardson, Vincent Emery, Grace John-Stewart, Jennifer A Slyker

    Published 2014-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Pregnancy and contraceptive use among participants of childbearing potential in the HVTN 705 HIV vaccine trial in Southern Africa

    Pregnancy and contraceptive use among participants of childbearing potential in the HVTN 705 HIV vaccine trial in Southern Africa by Pamela Mda, Kathryn Mngadi, Bo Zhang, Randy Burnham, Michal Juraska, Ollivier Hyrien, Nigel Garrett, Nigel Garrett, Thozama Dubula, Sinalo Toni, Sibi Joseph, Phillip Kotze, Susan Buchbinder, Susan Buchbinder, Azwidihwi Takalani, Frank Tomaka, Alexander Luedtke, Wouter Willems, Edith Swann, Julia Hutter, Huub Gelderblom, M. Juliana McElrath, Ludo Lavreys, Lynda Stranix-Chibanda, Alison C. Roxby, Alison C. Roxby, Linda-Gail Bekker, Linda-Gail Bekker, Glenda E. Gray

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Retrospective analysis of sex-disaggregated immune responses to ALVAC-HIV and bivalent subtype C gp120/MF59 HIV vaccines

    Retrospective analysis of sex-disaggregated immune responses to ALVAC-HIV and bivalent subtype C gp120/MF59 HIV vaccines by Cassie G. Ackerley, Srilatha Edupuganti, Chenchen Yu, Alison C. Roxby, Kelly E. Seaton, Linda-Gail Bekker, Mary Allen, Stephen C. DeRosa, Nicole L. Yates, Jack Heptinstall, Nonhlanhla N. Mkhize, Mookho Malahleha, Kathryn Mngadi, Brodie Daniels, Craig Innes, Briana D. Furch, Marguerite Koutsoukos, Guido Ferrari, Lynn Morris, David C. Montefiori, M. Juliana McElrath, Georgia D. Tomaras, Fatima Laher, Zoe Moodie

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Safety and immunogenicity after a 30-month boost of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120/MF59 vaccine boost (HVTN 100): A phase 1-2 randomized double-blind placebo-controlled trial.

    Safety and immunogenicity after a 30-month boost of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120/MF59 vaccine boost (HVTN 100): A phase 1-2 randomize... by Vimla Naicker, Fatima Laher, Linda-Gail Bekker, Kelly E Seaton, Mary Allen, Stephen De Rosa, Nicole L Yates, Nonhlanhla N Mkhize, Kevin Saunders, Jack Heptinstall, Mookho Malahleha, Kathryn Mngadi, Brodie Daniels, Craig Innes, Chenchen Yu, Tandile Modise, Valerie Bekker, Nicole Grunenberg, Briana Furch, Maurine D Miner, Sanjay Phogat, Carlos A Diazgranados, Sanjay Gurunathan, Marguerite Koutsoukos, Olivier Van Der Meeren, Alison C Roxby, Guido Ferrari, Lynn Morris, David Montefiori, M Juliana McElrath, Georgia D Tomaras, Zoe Moodie

    Published 2024-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: